期刊文献+

Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma:Relation to the immune cycle 被引量:1

下载PDF
导出
摘要 BACKGROUND Various histological types of gastric carcinomas(GCs)differ in terms of their pathogenesis and their preexisting background,both of which could impact the tumor immune microenvironment(TIME).However,the current understanding of the immune contexture of GC is far from complete.AIM To clarify the tumor-host immune interplay through histopathological features and the tumor immune cycle concept.METHODS In total,50 GC cases were examined(15 cases of diffuse GC,31 patients with intestinal-type GC and 4 cases of mucinous GC).The immunophenotype of GC was assessed and classified as immune desert(ID),immune excluded(IE)or inflamed(Inf)according to CD8+cell count and spatial pattern.In addition,CD68+and CD163+macrophages and programmed death-ligand 1(PD-L1)expression were estimated.RESULTS We found that GCs with different histological differentiation demonstrated distinct immune contexture.Most intestinal-type GCs had inflamed TIMEs rich in both CD8+cells and macrophages.In contrast,more aggressive diffuse-type GC more often possessed ID characteristics with few CD8+lymphocytes but abundant CD68+macrophages,while mucinous GC had an IE-TIME with a prevalence of CD68+macrophages and CD8+lymphocytes in the peritumor stroma.PD-L1 expression prevailed mostly in intestinal-type Inf-GC,with numerous CD163+cells observed.Therefore,GCs of different histological patterns have specific mechanisms of immune escape.While intestinal-type GC was more often related to PD-L1 expression,diffuse and mucinous GCs possessing more aggressive behavior demonstrated low immunogenicity and a lack of tumor antigen recognition or immune cell recruitment into the tumor clusters.CONCLUSION These data help to clarify the links between tumor histogenesis and immunogenicity for a better understanding of GC biology and more tailored patient management.
出处 《World Journal of Gastroenterology》 SCIE CAS 2021年第31期5259-5271,共13页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献2

二级参考文献25

  • 1Zheng, Yao,Wang, Lin,Zhang, Jian-Ping,Yang, Jing-Yan,Zhao, Zhu-Mei,Zhang, Xiao-Ying.Expression of p53,c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma[J].World Journal of Gastroenterology,2010,16(3):339-344. 被引量:34
  • 2Xiao-Jun Liu,Zhao-Feng Chen,Hai-Long Li,Ze-Nan Hu,Min Liu,Ai-Ping Tian,Da Zhao,Jing Wu,Yong-Ning Zhou,Liang Qiao.Interaction between cyclooxygenase-2,Snail,and E-cadherin in gastric cancer cells[J].World Journal of Gastroenterology,2013,19(37):6265-6271. 被引量:8
  • 3TakanoriMaruyama,YoshikiMizukami,YoshihikoKawaguchi,KousakuMimura,MitsuakiWatanabe,ShinichirouIzawa,HidekiFujii.Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor‐infiltrating lymphocytes, tumor‐draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer[J]. Cancer Science . 2010 (9)
  • 4Hazel Tye,Catherine L. Kennedy,Meri Najdovska,Louise McLeod,William McCormack,Norman Hughes,Anouk Dev,William Sievert,Chia Huey Ooi,Tomo-o Ishikawa,Hiroko Oshima,Prithi S. Bhathal,Andrew E. Parker,Masanobu Oshima,Patrick Tan,Brendan J. Jenkins.STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation[J]. Cancer Cell . 2012 (4)
  • 5Yung-Jue Bang,Eric Van Cutsem,Andrea Feyereislova,Hyun C Chung,Lin Shen,Akira Sawaki,Florian Lordick,Atsushi Ohtsu,Yasushi Omuro,Taroh Satoh,Giuseppe Aprile,Evgeny Kulikov,Julie Hill,Michaela Lehle,Josef Rüschoff,Yoon-Koo Kang.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial[J]. The Lancet . 2010 (9742)
  • 6Donald Richards,Darren M. Kocs,Alexander I. Spira,A. David McCollum,Sami Diab,Lanny I. Hecker,Allen Cohn,Feng Zhan,Lina Asmar.Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: results of a randomized phase 2 study[J].European Journal of Cancer.2013
  • 7Terence C.Chua,Neil D.Merrett.Clinicopathologic factors associated with HER2‐positive gastric cancer and its impact on survival outcomes—A systematic review[J].Int J Cancer.2012(12)
  • 8P.Allavena,A.Mantovani.Immunology in the clinic review series; focus on cancer: tumour‐associated macrophages: undisputed stars of the inflammatory tumour microenvironment[J].Clinical & Experimental Immunology.2012(2)
  • 9Heike Grabsch,Shivan Sivakumar,Sally Gray,Helmut E. Gabbert,Wolfram Müller.HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value – conclusions from 924 cases of two independent series[J].Cellular Oncology (-).2010(1-2)
  • 10Ji Hyun Song,Sang Gyun Kim,Sung-Ae Jung,Mi Kyoung Lee,Hyun Chae Jung,In Sung Song.The interleukin-8-251 AA genotype is associated with angiogenesis in gastric carcinogenesis in Helicobacter pylori -infected Koreans[J].Cytokine.2010(2)

共引文献40

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部